Visiongain Publishes Animal Autoimmune Disease Diagnostics Market Report to 2031

15 March 2021
Pharma

Visiongain has published a new report on Animal Autoimmune Disease Diagnostics Market Report to 2031: Forecasts By Test Type (Complete Blood Count, Thyroid Test, Biopsy Test, Urinalysis, DNA Amplification Test, and Immunoassays Test), By Indication (Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Autoimmune hemolytic anemia, Immune-related arthritis, and Others), By Animal Type (Companion Animal, Dogs, Cats, Horse, Live Stock Animal, Cattle, Swine, Poultry, Fish, and Sheep), By End User (Veterinary Hospital and Veterinary Clinics) PLUS COVID-19 Recovery Scenarios.

Global Animal Auto-Immune Disease Diagnostics market size is projected to reach US$ xx Billion in 2021 and is expected to display strong revenue growth through to 2031.

COVID-19 Impact on Animal Auto-Immune Disease Diagnostics Market
The COVID-19 pandemic has deleteriously affected all the countries and industries. Similarly, the animal auto-immune disease diagnostics market is anticipated to take a hit. The target industry is now facing challenges to manage the interrupted demand and supply of components. Also, unpredictable and disturbing supply chain activities and the unavailability of human resources are anticipated to impact the target industry growth. The animal auto-immune disease diagnostics market growth is expected to have an impact on the growing incidence of zoonotic infections, such as SARS-CoV-2 aka Covid-19, globally. There has been growth in animal health spending in current years, which is anticipated to push the target industry growth in the given time frame.

Market Drivers

Increasing Occurrences of Auto-immune Diseases in Animals
The increasing occurrence of zoonotic diseases in animals is expected to help in the growth of the animal auto-immune disease diagnostics market. The rising prevalence of animal disease epidemics, a growing population of animals, and favorable financial conditions of developing countries including Brazil, China, and India, are boosting the animal auto-immune disease diagnostics market growth.

The chances of transfer of zoonotic infection are quite high among immunosuppressed animals is a key factor accountable for the growing awareness of the auto-immune disease. For instance, there is a life-threatening chance of HIV transfer from the animal to an immunosuppressed person, the transmission of the allergic particle from companion animal to people are boosting the demand for autoimmune disease diagnosis tools, in turn aiding the target industry growth. The rising occurrence of autoimmune diseases in livestock animals has reduced the quality of meat consumed. Furthermore, the growing attention on livestock health among African countries which are the key exporters of livestock is growing the demand for animal autoimmune disease diagnosis.

Rising Number of Private Diagnostics Centers
The animal auto-immune disease diagnostics market growth is predominantly attributed to the growing acceptance of point-of-care and quick diagnostic tests, the rising number of private diagnostic centers, and the growing awareness regarding animal auto-immune diseases and initiatives taken by health organizations and government. Besides, improving veterinary healthcare infrastructure in developing countries and the increasing number of regulatory endorsements for immunoassay techniques further offer lucrative growth opportunities for the global key players operating in the animal auto-immune disease diagnostics market. However, the shortage of skilled laboratory technicians and the high price of diagnostic imaging systems & procedures may hinder the target industry growth at a certain point.

Market Opportunities

The Growing Potential of Developing Economies
Developing nations such as China, India offer lucrative opportunities for the global key players operating in the animal auto-immune disease diagnostics industry. The Asia Pacific and African markets are observing the growth in the adoption of animal healthcare services particularly for livestock due to the growing demand for meat and other animal products in the cosmetic and pharmaceutical industry. Besides, raising awareness for risk of zoonotic illness transmission, growing accessibility of veterinary care centers which are linking the human and pet health issues.

Competitive Landscape
Key players operating in the global Animal Auto-Immune Disease Diagnostics market are IDEXX Laboratories, VCA, Inc., Elabscience Biotechnology Co. Ltd, ABAXIS, Inc. Zoetis, Inc., ID Vet, Neogen Corporation, Accuplex Diagnostics, Thermo Fisher Scientific, Inc., GE Healthcare, Mindray Medical International Ltd., Heska Corporation, and Agfa Healthcare.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

Read

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

Read

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

Read

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever